Browse by regulation1 article · 1 high
21 CFR 211.48 / 21 CFR 211.192
Every DSRV article whose Regulatory Snapshot cites 21 CFR 211.48 / 21 CFR 211.192: the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.
Inspection exposure across the set
- What has FDA cited under 21 CFR 211.48 / 21 CFR 211.192?
- 1 DSRV article cite 21 CFR 211.48 / 21 CFR 211.192. Enforcement cases behind them: FDA Warning Letters: Creative Essences (09/25/2025), SV Labs (12/09/2025), Patcos Cosmetics (03/12/2026). Inspection exposure across them: 1 high.
- What does DSRV recommend for 21 CFR 211.48 / 21 CFR 211.192?
- From the newest article (FDA’s 2025–2026 Warning-Letter Pattern: Water Systems Are Still Breaking Quality Systems, Not Just Utilities): When water-system excursions occur, treat them as quality-system governance events rather than isolated engineering work orders. DSRV is decision support, not legal advice; verify against the official source each article names.
In brief
Address this risk
Pressure-test your evidence before an inspector reads it
Bring the document that has to hold up under 21 CFR 211.48 / 21 CFR 211.192. DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.
Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.